chr18-3193840-T-G
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003803.4(MYOM1):c.409A>C(p.Met137Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000821 in 1,461,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M137V) has been classified as Uncertain significance.
Frequency
Consequence
NM_003803.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| MYOM1 | ENST00000356443.9 | c.409A>C | p.Met137Leu | missense_variant | Exon 3 of 38 | 1 | NM_003803.4 | ENSP00000348821.4 | ||
| MYOM1 | ENST00000261606.11 | c.409A>C | p.Met137Leu | missense_variant | Exon 3 of 37 | 1 | ENSP00000261606.7 | |||
| ENSG00000265399 | ENST00000580139.1 | n.121-36T>G | intron_variant | Intron 1 of 4 | 2 | 
Frequencies
GnomAD3 genomes  
GnomAD2 exomes  AF:  0.0000362  AC: 9AN: 248934 AF XY:  0.0000296   show subpopulations 
GnomAD4 exome  AF:  0.00000821  AC: 12AN: 1461488Hom.:  0  Cov.: 30 AF XY:  0.00000550  AC XY: 4AN XY: 727008 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The p.M137L variant (also known as c.409A>C), located in coding exon 2 of the MYOM1 gene, results from an A to C substitution at nucleotide position 409. The methionine at codon 137 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Hypertrophic cardiomyopathy    Uncertain:1 
This sequence change replaces methionine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 137 of the MYOM1 protein (p.Met137Leu). This variant is present in population databases (rs765511668, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with MYOM1-related conditions. ClinVar contains an entry for this variant (Variation ID: 525017). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at